Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 39.90
+2.10 (5.56%)
Jan 21, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 28 billion as of January 21, 2026. Its market cap has increased by 729.56% in one year.
Market Cap
28.00B
Enterprise Value
28.14B
Revenue
1.30B
Ranking
n/a
PE Ratio
103.58
Stock Price
39.90
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 28.00B, an increase of 171.45%. That is a compound annual growth rate of 34.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 27.98B | 18.64% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 60.07B |
| TransThera Sciences (Nanjing) | 36.95B |
| Shanghai Junshi Biosciences | 36.31B |
| Shanghai Henlius Biotech | 34.29B |
| Duality Biotherapeutics | 31.74B |
| Genscript Biotech | 30.26B |
| InnoCare Pharma | 23.79B |
| Ascentage Pharma Group International | 18.73B |